vitilogo
Conditions
Interventions
Case group:Scale
control group:Cognitive Assessment
Sponsors
The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-70 years, all patients are right-handed; 2. In accordance with the diagnostic criteria of "China Clinical Dermatology"; 3. This study was approved by the hospital ethics committee. All subjects signed a written informed consent form; 4. Two trained evaluators conduct tests and medical records review on all patients.
Exclusion criteria
Exclusion criteria: 1. Patients with vague diagnosis; 2. Patients with mental disorders such as schizophrenia; 3. Patients with impaired consciousness such as delirium; 4. Unable to cooperate due to deafness, blindness or other physical diseases; 5. Others that may lead to recognition Diseases with cognitive impairment, such as syphilis infection, vitamin B12 deficiency, systemic lupus erythematosus and thyroid dysfunction; 6. Patients with Hamilton Depression Rating Scale (HAMD-17) score greater than 17 are used to exclude depression-related recognition Cognitive dysfunction; because age and education have been proven to affect cognitive function, the patient group and the control group are matched with age and years of education; 7. Recent history of sedative drugs and various drugs that may affect cognitive function.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mini-mental State Examination;Montreal Congnitive Assessment; | — |
Countries
China
Contacts
Public ContactJingjing Huang
The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University
Outcome results
None listed